TP53 and adenocarcinoma: Further support for a correlation between tumor morphology and SMAD4 mutational status was obtained from a rare mixed adenocarcinoma and neuroendocrine carcinoma of the colon, in which histologically divergent tumor regions manifested distinct SMAD4 mutations despite conservation of identical KRAS and TP53 mutations.